Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7,049 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1988 Dec;15(12):1833-40. J Rheumatol. 1988. PMID: 3068365 Clinical Trial.
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index.
Bellamy N, Kean WF, Buchanan WW, Gerecz-Simon E, Campbell J. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1992 Jan;19(1):153-9. J Rheumatol. 1992. PMID: 1556679 Clinical Trial.
Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1992 Mar;19(3):436-43. J Rheumatol. 1992. PMID: 1578460
Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.
Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1992 Mar;19(3):444-50. J Rheumatol. 1992. PMID: 1578461
Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise.
Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1992 Mar;19(3):451-7. J Rheumatol. 1992. PMID: 1578462
Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trial.
Bellamy N, Beaulieu A, Bombardier C, Huang S, Kraag G, Ménard HA, Russell AS, Tannenbaum H, Willans M, Campbell J. Bellamy N, et al. Among authors: campbell j. Curr Med Res Opin. 1992;12(10):640-51. doi: 10.1185/03007999209111531. Curr Med Res Opin. 1992. PMID: 1633722 Clinical Trial.
A preliminary study of magnetic resonance relaxation times (T1 and T2) in inflammatory and degenerative synovial fluids.
Bellamy N, Thompson RT, Driedger AA, Roth JH, Peemoeller H, Campbell J. Bellamy N, et al. Among authors: campbell j. Br J Rheumatol. 1991 Dec;30(6):464-7. doi: 10.1093/rheumatology/30.6.464. Br J Rheumatol. 1991. PMID: 1747704
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1991 Nov;18(11):1701-8. J Rheumatol. 1991. PMID: 1787492
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.
Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1991 Nov;18(11):1709-15. J Rheumatol. 1991. PMID: 1787493
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. Among authors: campbell j. J Rheumatol. 1991 Nov;18(11):1716-22. J Rheumatol. 1991. PMID: 1787494
7,049 results
Jump to page
Feedback